( September 11, 2026, 10:41 AM EDT) -- SAN DIEGO — A federal judge in California granted a medical device company and its executives’ motion to dismiss the lead plaintiff’s second amended securities class action complaint, finding that the plaintiff failed to show that the executives’ public statements about the company’s share of the Type 2 diabetes basal prescription market were false or misleading....